<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PYRANTEL PAMOATE</span><br/>(pi-ran'tel)<br/><span class="topboxtradename">Antiminth, </span><span class="topboxtradename">Pin-Rid<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">anthelmintic</span><br/><b>Prototype: </b>Mebendazole<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>180 mg capsules; 50 mg/mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Exerts selective depolarizing neuromuscular blocking action, which results in spastic paralysis of worm; also inhibits cholinesterase.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Evacuation of worms from intestines.</p>
<h1><a name="uses">Uses</a></h1>
<p> <i>Enterobius vermicularis</i> (pinworm) and <i>Ascaris lumbricoides</i> (roundworm) infestations.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Hookworm infestations; trichostrongylosis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Safety during pregnancy (category C), lactation, or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Liver dysfunction; malnutrition; dehydration; anemia.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Pinworm or Roundworm</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">PO</span> 11 mg/kg as a single dose (max: 1 g)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Shake suspension well before pouring it to ensure accurate dosage.</li>
<li>Give with milk or fruit juices and without regard to prior ingestion of food or time of day.</li>
<li>Store below 30° C (86° F). Protect from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Dizziness, headache, drowsiness, insomnia. <span class="typehead">GI:</span> Anorexia, <span class="speceff-common">nausea,</span> vomiting, abdominal distention, diarrhea, <span class="speceff-common">tenesmus,</span> transient elevation of AST. <span class="typehead">Skin:</span> Skin rashes. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Piperazine</b> and pyrantel may be mutually antagonistic. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Poorly absorbed from GI tract. <span class="typehead">Peak:</span> 13 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> &gt;50% excreted in feces, 7% in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Monitor baseline and periodic AST/ALT in individuals with known liver dysfunction.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in other potentially hazardous activities until response to drug is known.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>